Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > ORGANIZATION
ORGANIZATION
- Funding Disclosures by 5 More FPMAJ Trade Groups to Get Underway in FY2014
March 27, 2014
- JPMA Reinstates Nihon Pharmaceutical Membership after 1-Year Suspension
March 25, 2014
- GHIT Fund Announces New Grants to Develop Treatments for Tropical Diseases, Novel Tuberculosis Vaccine
March 24, 2014
- JPMA Urges Takeda to Improve Promotion Regime over CASE-J
March 24, 2014
- Japanese Drug Makers Conduct MRCTs in More Countries, but Japan Ranks Just 24th as Trial Location: JPMA Survey
March 18, 2014
- JPWA Members to Display Delivery Prices without Tax from October
March 14, 2014
- 3,551 Contract Medical Sales Reps Work in Japan, Up 5.5%: Survey
March 13, 2014
- PhRMA Issues Principles on Investigator-Initiated Studies, Urges Drug Makers Not to Offer Labor
March 12, 2014
- PhRMA “Disappointed” by Rule Changes for Foreign Price Adjustments: New Japan Committee Chair
March 12, 2014
- FPMAJ Generic Guidelines Urge Makers to Create “Stable Supply” Officer Post
March 7, 2014
- JPMA Requests Takeda to Submit Report over CASE-J Issue
March 6, 2014
- Penalty for Lengthy Drug Price Haggling – Interview 3: JMA Exec Suzuki Calls for Cooperation to Defend Universal Healthcare
March 3, 2014
- Medwatcher Opposes Resumption of Active Recommendation for HPV Vaccines by Government
February 26, 2014
- Tokyo Pharmacist Head Yamamoto Elected Next President of JPA
February 26, 2014
- Penalty for Lengthy Drug Price Haggling – Interview 2: “Rule Could Ruin Trust with Wholesalers,” Says NPhA Chief Nakamura
February 25, 2014
- Rule to Reduce Medical Fees at Hospitals with Low Price Settlement Rates Reflects Chuikyo’s Concerns about Profits: Kenporen
February 24, 2014
- NPhA Member Pharmacies Prepping to Form Bidding Body for Drug Purchasing, Launch Slated in Late March
February 20, 2014
- Hospitals Will “Respond Calmly” to Rule to Reduce Medical Fees Claimed by Facilities with Low Price Settlement Rates: Presidents of JHA, AJHA
February 19, 2014
- NPhA Objects to JPA Response on Rule to Reduce Dispensing Fees Claimed by Pharmacies with Low Price Settlement Rates
February 18, 2014
- MSD’s Alvarez Moved Up to Chair of PhRMA Japan Committee
February 13, 2014
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…